Header

Skip to main content

Paradigm Shift Therapeutics

Paradigm Shift Therapeutics is a biotechnology research institute that develops inhibitors for treating patients with cancer.

Primera Therapeutics

Primera Therapeutics focuses on developing gene editing therapies targeting mitochondrial DNA mutations, addressing the root cause of mitochondrial diseases, which can lead to severe childhood diseases, chronic kidney disease, and metabolic disorders.

ProMetic BioTherapeutics

ProMetic BioTherapeutics, Inc. specializes in pharmaceutical preparation manufacturing.

Meso Scale Diagnostics

Meso Scale Discovery (MSD) is a global leader in the development, manufacture, and commercialization of innovative assays and instruments for the measurement of molecules in biological samples.

Neurocytonix

NeuroCytonix focuses on biomedical technologies and has built a cutting-edge medical biotechnology company centered on tissue creation and regeneration.

NovaBridge Biosciences

NovaBridge Biosciences is a biotechnology platform that develops precision immuno-oncology treatment of cancer.

OncoC4

OncoC4 is a clinical-stage biotechnology company that is actively engaged in the discovery and development of novel biologics for the potential treatment of cancer and neurodegenerative disease.

Io Biotech

IO Biotech is a clinical stage biotech company developing disruptive immune therapies for immunological treatment of cancer.

This website uses cookies

This site uses cookies to provide more personalized content, social media features, and ads, and to analyze our traffic. We might share information about your use of our site with our social media, advertising, and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. We will never sell your information or share it with unaffiliated entities.